FDA grants fast track review to Glenveigh Digoxin Immune Fab
Glenveigh Medical founder and chairman Dr. David Adair said DIF is taking treatment to a level that hasn’t been available before for women with severe preeclampsia. "In particular,
SK bioscience is set to lead the Gates Foundation-fundedResearch Optimization & Trial Outcome Recommender (ROTOR) project, an AI-based platform aimed at reducing uncertainty in vaccine-development decisions.
The voice recognition technology was designed to confirm prescription medications before administration at home or in medical center, thereby preventing medication errors. SafeCode technology provides access to prescription